Press release BoxID: 454895 (Ypsomed AG)
  • Ypsomed AG
  • Brunnmattstrasse 6
  • 3401 Burgdorf
  • Contact person
  • Benjamin Overney
  • +41 (34) 4244159

Ypsomed strengthens company management

(PresseBox) (Burgdorf, ) The Ypsomed Group is strengthening its management: the Technology and Operations divisions, headed by Hans Ulrich Lehmann and Benjamin Reinmann respectively, are now directly repre-sented on the management board of the Burgdorf-based diabetes specialist. This structural adjustment is geared towards ensuring that the core competencies of the Ypsomed Group, namely innovation and manufacturing, are ade-quately represented within operational management, and towards achieving strategic objectives. The Board of Direc-tors decided on the measure based on a prior structural analysis.

Ypsomed AG

The Ypsomed Group is a leading independent developer and manufacturer of injection systems for self-medication and a well-known diabetes specialist with more than 25 years' experience. The Ypsomed Group, which emerged in 2003 from the Disetronic Group, offers insulin pumps, injection systems and pen needles for diabetes, growth hor-mone and infertility treatments as well as for other therapeutic purposes. Ypsomed is an innovation and technology leader with an extensive patent portfolio and is the preferred partner of pharmaceutical and biotech companies in the self-medication sector. The Ypsomed Group has its headquarters in Burgdorf, Switzerland. It has several manufac-turing sites in Switzerland as well as leading independent diabetes product sales companies throughout Europe. The Ypsomed Group employs approximately 1'150 employees.